Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...
TipRanks on MSN
CRISPR Therapeutics AG: Stock surge amid challenges
Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...
The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...
The "Mice Model Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.The mice model market is experiencing robust growth, with projected expansion from USD 1.61 ...
As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...
Chardan lowered the firm’s price target on Crispr Therapeutics (CRSP) to $74 from $82 and keeps a Buy rating on the shares. The firm updated the ...
When what was previously scarce suddenly becomes abundant, look for the new scarcity because that is what creates leverage.
News-Medical.Net on MSN
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...
9don MSN
Are university policies holding science back? Study shows how patenting boosts pure research
When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback